Search

Rheinbay, E., P. Parasuraman, J. Grimsby, G. Tiao, J. M. Engreitz, J. Kim, M. S. Lawrence, et al. 2017. “Recurrent and Functional Regulatory Mutations in Breast Cancer”. Nature 547: 55-60.

Sharifnia, T., V. Rusu, F. Piccioni, M. Bagul, M. Imielinski, A. D. Cherniack, C. S. Pedamallu, et al. 2014. “Genetic Modifiers of EGFR Dependence in Non-Small Cell Lung Cancer”. Proc Natl Acad Sci U S A 111: 18661-6.

Shee, K., A. Jiang, F. S. Varn, S. Liu, N. A. Traphagen, P. Owens, C. X. Ma, et al. 2019. “Cytokine Sensitivity Screening Highlights BMP4 Pathway Signaling As a Therapeutic Opportunity in ER(+) Breast Cancer”. FASEB J 33: 1644-57.

Ebert, B. L., M. M. Lee, J. L. Pretz, A. Subramanian, R. Mak, T. R. Golub, and C. A. Sieff. 2005. “An RNA Interference Model of RPS19 Deficiency in Diamond-Blackfan Anemia Recapitulates Defective Hematopoiesis and Rescue by Dexamethasone: Identification of Dexamethasone-Responsive Genes by Microarray”. Blood 105: 4620-6.

Ebert, B. L., J. Pretz, J. Bosco, C. Y. Chang, P. Tamayo, N. Galili, A. Raza, et al. 2008. “Identification of RPS14 As a 5q- Syndrome Gene by RNA Interference Screen”. Nature 451: 335-9.

Filbin, M. G., I. Tirosh, V. Hovestadt, M. L. Shaw, L. E. Escalante, N. D. Mathewson, C. Neftel, et al. 2018. “Developmental and Oncogenic Programs in H3K27M Gliomas Dissected by Single-Cell RNA-Seq”. Science 360: 331-35.

Ghandi, M., F. W. Huang, J. Jane-Valbuena, G. V. Kryukov, C. C. Lo, 3rd McDonald E. R., J. Barretina, et al. 2019. “Next-Generation Characterization of the Cancer Cell Line Encyclopedia”. Nature 569: 503-8.

Golub, T. R., A. Goga, G. F. Barker, D. E. Afar, J. McLaughlin, S. K. Bohlander, J. D. Rowley, O. N. Witte, and D. G. Gilliland. 1996. “Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia”. Mol Cell Biol 16: 4107-16.

Gustafsdottir, S. M., V. Ljosa, K. L. Sokolnicki, J. Anthony Wilson, D. Walpita, M. M. Kemp, K. Petri Seiler, et al. 2013. “Multiplex Cytological Profiling Assay to Measure Diverse Cellular States”. PLoS One 8: e80999.

Hahn, C. K., J. E. Berchuck, K. N. Ross, R. M. Kakoza, K. Clauser, A. C. Schinzel, L. Ross, et al. 2009. “Proteomic and Genetic Approaches Identify Syk As an AML Target”. Cancer Cell 16: 281-94.